Healthcare Industry News: vena cava filter
News Release - January 23, 2007
Cook Medical Names Rob Lyles as Vice President
Will Lead Company's Global Diagnostic and Interventional Products DivisionBLOOMINGTON, Ind.--(HSMN NewsFeed)--Rob Lyles has been named vice president for Cook Medical's diagnostic and interventional (D&I) products division. Along with his new title of vice president, Lyles will retain his position as global business unit leader for D&I, Cook's largest medical division.
Lyles has held several positions since joining Cook in 2003, serving first as director of sales and national sales manager for D&I. His role was expanded to include business unit leader for the U.S., Latin America and Asia in late 2003. Lyles was then named to his current position in July 2004, serving as director, global business unit leader for D&I since that time.
"Our diagnostic and interventional products division represents the core interventional medical technologies that launched the entire Cook Medical organization worldwide," said Kem Hawkins, president of Cook Group "Leading this division is an enormous responsibility, and in the three and a half years Rob has been with us he has shown that he's more than up to the challenge. I am proud to add him to the company's executive management team."
"At Cook Medical, we are crossing new frontiers in interventional medical technology everyday. The convergence of medical devices, biotechnology, gene therapy, pharmaceuticals and cell-based therapies creates enormous opportunities to attack diseases like cancer, peripheral vascular disease and stroke using minimally invasive therapeutic procedures," Lyles said. "Cook is one of very few medical technology companies today that is bringing together this broad array of innovations under one banner.
"Even though the technology is getting more complicated, our approach to the market remains simple," added Lyles. "We identify a clinical problem, we work with physicians to create a solution for patients and we offer that solution to the market at a fair price. Cook's unique blend of high-tech products and straightforward business dealings has been the foundation of our success for 44 years. I'm thrilled to be part of the team that is taking that same philosophy into the future. The road ahead for Cook, and for patients worldwide, is incredibly positive."
Lyles, who holds a BS degree from Abilene Christian University and an MS degree from Indiana University, first joined Cook in 2003. In 2006 he was inducted as a Hoosier Fellow at the Randall L. Tobias Center for Excellence in Leadership at Indiana University.
Prior to joining Cook, Lyles held leadership and management positions in a number of organizations including a marketing firm, an early-stage technology company (Friendly Robotics) and most recently with a Fortune 500 company (Royal Dutch Philips).
He resides in Bloomington, Indiana, with his wife, Jill, and their three children.
About Cook
The world's largest privately held manufacturer of medical devices with international headquarters in Bloomington, Ind., COOK® (www.cookmedical.com/) is a leading designer, manufacturer and global distributor of minimally invasive medical device technology for diagnostic and therapeutic procedures. Since its founding in 1963, Cook has created innovative technologies for drug-eluting and bare metal stents, aortic and vascular endografts, catheters, wire guides, introducer needles and sheaths, embolization coils, medical biomaterials and contract manufacturing of biopharmaceuticals, vena cava filters and other minimally invasive medical devices for radiology, cardiology, urology and women's health, critical care medicine, surgery, gastroenterology, bone access and endovascular therapies.
Source: Cook Medical
Issuer of this News Release is solely responsible for its
content.
Please address inquiries directly to the issuing company.
